小儿复核型间变性大细胞淋巴瘤1例。

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Danqin Zheng, Songjie Zhu, Huajuan Ruan, Wenyun Zhang, Danqin Zheng
{"title":"小儿复核型间变性大细胞淋巴瘤1例。","authors":"Danqin Zheng, Songjie Zhu, Huajuan Ruan, Wenyun Zhang, Danqin Zheng","doi":"10.7754/Clin.Lab.2024.240841","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anaplastic large cell lymphoma (ALCL) is a rare type of peripheral T-cell lymphoma, accounting for a small percentage of adult and childhood lymphomas. The scarcity of reports on relapsed or refractory ALCL in children, especially with complex karyotypes, highlights the need for detailed case studies.</p><p><strong>Methods: </strong>We report the case of a 9-year-old girl diagnosed with ALK-positive anaplastic large cell lymphoma, complicated by complex karyotype abnormalities and bone marrow involvement. The patient underwent multiple chemotherapy regimens, including the P regimen, AV1, BV1, AV2, BV2, and AV3 protocols, followed by continuous monitoring through bone marrow biopsies and PET/CT imaging. Despite initial treatment efforts, the disease relapsed, and the patient's condition deteriorated.</p><p><strong>Results: </strong>Initial treatment with chemotherapy led to a transient reduction in disease activity, as evidenced by bone marrow biopsies showing no malignancy. However, PET/CT scans revealed persistent metabolic activity in multiple skeletal sites, indicating incomplete remission. The patient's condition further relapsed with significant disease progression, culminating in sepsis, heart failure, and active bleeding, which were unresponsive to treatment.</p><p><strong>Conclusions: </strong>This case underscores the aggressive nature of pediatric ALCL with complex karyotypes and highlights the challenges associated with its treatment. Despite intensive chemotherapy, the disease exhibited rapid relapse and resistance, ultimately leading to a fatal outcome. This report contributes to the limited literature on pediatric ALCL, particularly in cases with complex cytogenetic profiles, and emphasizes the need for novel thera-peutic approaches and early intervention strategies.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 2","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Case of Relapsed and Refractory Pediatric Anaplastic Large Cell Lymphoma with Complex Karyotype.\",\"authors\":\"Danqin Zheng, Songjie Zhu, Huajuan Ruan, Wenyun Zhang, Danqin Zheng\",\"doi\":\"10.7754/Clin.Lab.2024.240841\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Anaplastic large cell lymphoma (ALCL) is a rare type of peripheral T-cell lymphoma, accounting for a small percentage of adult and childhood lymphomas. The scarcity of reports on relapsed or refractory ALCL in children, especially with complex karyotypes, highlights the need for detailed case studies.</p><p><strong>Methods: </strong>We report the case of a 9-year-old girl diagnosed with ALK-positive anaplastic large cell lymphoma, complicated by complex karyotype abnormalities and bone marrow involvement. The patient underwent multiple chemotherapy regimens, including the P regimen, AV1, BV1, AV2, BV2, and AV3 protocols, followed by continuous monitoring through bone marrow biopsies and PET/CT imaging. Despite initial treatment efforts, the disease relapsed, and the patient's condition deteriorated.</p><p><strong>Results: </strong>Initial treatment with chemotherapy led to a transient reduction in disease activity, as evidenced by bone marrow biopsies showing no malignancy. However, PET/CT scans revealed persistent metabolic activity in multiple skeletal sites, indicating incomplete remission. The patient's condition further relapsed with significant disease progression, culminating in sepsis, heart failure, and active bleeding, which were unresponsive to treatment.</p><p><strong>Conclusions: </strong>This case underscores the aggressive nature of pediatric ALCL with complex karyotypes and highlights the challenges associated with its treatment. Despite intensive chemotherapy, the disease exhibited rapid relapse and resistance, ultimately leading to a fatal outcome. This report contributes to the limited literature on pediatric ALCL, particularly in cases with complex cytogenetic profiles, and emphasizes the need for novel thera-peutic approaches and early intervention strategies.</p>\",\"PeriodicalId\":10384,\"journal\":{\"name\":\"Clinical laboratory\",\"volume\":\"71 2\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical laboratory\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7754/Clin.Lab.2024.240841\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.240841","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:间变性大细胞淋巴瘤(ALCL)是一种罕见的外周t细胞淋巴瘤,在成人和儿童淋巴瘤中占很小的比例。关于儿童复发或难治性ALCL的报道很少,特别是具有复杂核型的儿童,这突出了详细病例研究的必要性。方法:我们报告一个9岁女孩诊断为alk阳性间变性大细胞淋巴瘤,并伴有复杂的核型异常和骨髓受累。患者接受了多种化疗方案,包括P方案、AV1、BV1、AV2、BV2和AV3方案,随后通过骨髓活检和PET/CT成像进行持续监测。尽管最初的治疗努力,疾病复发,病人的病情恶化。结果:最初的化疗治疗导致疾病活动的短暂减少,骨髓活检显示无恶性肿瘤。然而,PET/CT扫描显示多个骨骼部位持续的代谢活动,表明不完全缓解。患者病情进一步复发,疾病进展明显,最终出现败血症、心力衰竭和活动性出血,对治疗无反应。结论:该病例强调了具有复杂核型的儿科ALCL的侵袭性,并强调了与治疗相关的挑战。尽管进行了强化化疗,但该疾病表现出快速复发和耐药性,最终导致致命的结果。本报告对儿科ALCL的有限文献,特别是复杂细胞遗传学的病例做出了贡献,并强调需要新的治疗方法和早期干预策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Case of Relapsed and Refractory Pediatric Anaplastic Large Cell Lymphoma with Complex Karyotype.

Background: Anaplastic large cell lymphoma (ALCL) is a rare type of peripheral T-cell lymphoma, accounting for a small percentage of adult and childhood lymphomas. The scarcity of reports on relapsed or refractory ALCL in children, especially with complex karyotypes, highlights the need for detailed case studies.

Methods: We report the case of a 9-year-old girl diagnosed with ALK-positive anaplastic large cell lymphoma, complicated by complex karyotype abnormalities and bone marrow involvement. The patient underwent multiple chemotherapy regimens, including the P regimen, AV1, BV1, AV2, BV2, and AV3 protocols, followed by continuous monitoring through bone marrow biopsies and PET/CT imaging. Despite initial treatment efforts, the disease relapsed, and the patient's condition deteriorated.

Results: Initial treatment with chemotherapy led to a transient reduction in disease activity, as evidenced by bone marrow biopsies showing no malignancy. However, PET/CT scans revealed persistent metabolic activity in multiple skeletal sites, indicating incomplete remission. The patient's condition further relapsed with significant disease progression, culminating in sepsis, heart failure, and active bleeding, which were unresponsive to treatment.

Conclusions: This case underscores the aggressive nature of pediatric ALCL with complex karyotypes and highlights the challenges associated with its treatment. Despite intensive chemotherapy, the disease exhibited rapid relapse and resistance, ultimately leading to a fatal outcome. This report contributes to the limited literature on pediatric ALCL, particularly in cases with complex cytogenetic profiles, and emphasizes the need for novel thera-peutic approaches and early intervention strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信